Get 20% lifetime commission for referring investors to digrin.com
here.
KALA BIO, Inc. (KALA) Financials
KALA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 10.6 million | 1.5 million |
| March 31, 2026 | 12.3 million | 1.6 million |
| Dec. 31, 2025 | 9.5 million | 2.5 million |
| Sept. 30, 2025 | 25.0 million | 33.7 million |
KALA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -1.5 million | -136000 |
| March 31, 2026 | -2.9 million | -471000 |
| Dec. 31, 2025 | -4.6 million | 401000 |
| Sept. 30, 2025 | -10.9 million | 2.0 million |
KALA Net Income
No data available :(
KALA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 7.2 million | - | - |
| March 31, 2026 | 8.8 million | - | - |
| Dec. 31, 2025 | 7.6 million | - | - |
| Sept. 30, 2025 | 21.1 million | - | 1.5 million |
KALA Shares Outstanding
KALA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 59000 | 1.7 million | - |
| March 31, 2026 | 16000 | 61000 | 1.7 million | - |
| Dec. 31, 2025 | 16000 | 312000 | 9.9 million | - |
| Sept. 30, 2025 | 16000 | 6.1 million | 4.5 million | - |
KALA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 54000 |
| Dec. 31, 2025 | - | 54000 |
| Sept. 30, 2025 | - | 128000 |
KALA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
KALA
Price: $0.19
52 week price:
Earnings Per Share: -9.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.0 million
Ebitda: -9.9 millionMarket Capitalization: 7.0 million